Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
14.35
-0.46 (-3.11%)
Oct 9, 2025, 12:06 PM EDT - Market open
Prenetics Global Revenue
Prenetics Global had revenue of $17.68M in the quarter ending June 30, 2025, with 197.57% growth. This brings the company's revenue in the last twelve months to $57.05M, up 151.74% year-over-year. In the year 2024, Prenetics Global had annual revenue of $30.62M with 40.83% growth.
Revenue (ttm)
$57.05M
Revenue Growth
+151.74%
P/S Ratio
3.36
Revenue / Employee
$200,179
Employees
285
Market Cap
187.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.62M | 8.88M | 40.83% |
| Dec 31, 2023 | 21.74M | 8.58M | 65.17% |
| Dec 31, 2022 | 13.16M | 631.26K | 5.04% |
| Dec 31, 2021 | 12.53M | -52.65M | -80.77% |
| Dec 31, 2020 | 65.18M | 55.95M | 605.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
PRE News
- 11 hours ago - Prenetics: A Cautious Buy Based On Strong Sales Growth - Seeking Alpha
- 1 day ago - Prenetics' IM8 Launches Daily Ultimate Longevity, First Supplement to Target All 12 Hallmarks of Aging - GlobeNewsWire
- 9 days ago - Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore - GlobeNewsWire
- 27 days ago - Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End - GlobeNewsWire
- 3 months ago - World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder - GlobeNewsWire
- 4 months ago - Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board - GlobeNewsWire
- 4 months ago - Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction - GlobeNewsWire
- 7 months ago - Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market - GlobeNewsWire